Evidence map›Paper›PMID 42166779›Full record

ArticleHealth reports2026

Enhancing the OncoSim-Breast model using Canadian breast density information.

Oguzhan Alagoz, Rochelle Garner, Claude Nadeau, Andrew Coldman, Jean Hai Ein Yong, Martin J Yaffe, James G Mainprize, Dori Simeonov

Abstract read
In one paragraph

Article in Health reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oguzhan AlagozDepartment of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Rochelle GarnerHealth Analysis and Modelling Division, Statistics Canada, Ottawa, Ontario, Canada.
Claude NadeauHealth Analysis and Modelling Division, Statistics Canada, Ottawa, Ontario, Canada.
Andrew ColdmanPopulation Health Sciences, BC Cancer, Vancouver, British Columbia, Canada.
Jean Hai Ein YongCancer Systems and Innovation Division, Canadian Partnership Against Cancer, Toronto, Ontario, Canada.
Martin J YaffeSunnybrook Research Institute, Toronto, Ontario, Canada.
James G MainprizeSunnybrook Research Institute, Toronto, Ontario, Canada.
Dori SimeonovCancer Systems and Innovation Division, Canadian Partnership Against Cancer, Toronto, Ontario, Canada.

Funding

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - SupplementU01CA253911 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ALAGOZ, OGUZHAN, DE KONING, HARRY J · 2020 to 2025
$10.6M
NCI NIH HHS U01 CA253911
6 · The paper itself

Abstract

Background: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters into the OncoSim-Breast model. Data and methods: Breast density-specific inputs were integrated into OncoSim-Breast using data from five Canadian provinces. Three key parameters - prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity) - were estimated by age group and breast density category, following the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS) classification (categories A to D). Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry. Results: The prevalence of dense breasts declined with age: BI-RADS categories C and D accounted for 58% of women younger than 50 years and 26% of those aged 70 and older. Digital mammography sensitivity also decreased with increasing density: among women younger than 50 years, sensitivity was 88% for Category A and 69% for Category D. The updated OncoSim-Breast model accurately replicated age-specific incidence, age-adjusted incidence, and stage distribution based on historical data from the Canadian Cancer Registry (2010 to 2019). Interpretation: Incorporating breast density-specific parameters substantially improved the accuracy and policy relevance of OncoSim-Breast. The updated model provides a validated tool to inform screening policy decisions for Canadian women, allowing consideration for the effect of the variability of breast density among women.

Indexed as

BreastBreast DensityBreast NeoplasmsMammographyAdultAgedAge FactorsCanadaEarly Detection of CancerFemaleHumansMiddle AgedPrevalenceRegistriesSensitivity and Specificitybreast cancer in Canadabreast densityscreening mammographysimulation modelingsupplemental breast cancer screening

Identifiers

PMID42166779
PMCPMC13508063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.